Richard Steingart

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi request reprint Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management
    Richard M Steingart
    Memorial Sloan Kettering Cancer Center, New York, NY Electronic address
    Semin Oncol 40:690-708. 2013
  2. doi request reprint Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
    Richard M Steingart
    Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am Heart J 163:156-63. 2012
  3. ncbi request reprint Preoperative exercise echocardiography and perioperative cardiovascular outcomes in elderly patients undergoing cancer surgery
    Abu Shoyeb
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Geriatr Cardiol 15:338-44. 2006
  4. doi request reprint The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Chau Dang
    Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Howard 713, New York, NY 10021, USA
    J Clin Oncol 26:1216-22. 2008
  5. pmc Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction
    Patrick G Morris
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 27:6117-23. 2009
  6. pmc Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea
    Chau Dang
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 28:2982-8. 2010
  7. doi request reprint Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients
    Jurgen Rademaker
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1270 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 191:32-7. 2008
  8. doi request reprint Cardiac disease and heart failure in cancer patients: is our training adequate to provide optimal care?
    Carol L Chen
    Cardiology Division, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Howard 809, New York, NY 10065, USA
    Heart Fail Clin 7:357-62. 2011
  9. ncbi request reprint Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry
    Marc Klapholz
    Saint Vincent Catholic Medical Centers, New York, New York, USA
    J Am Coll Cardiol 43:1432-8. 2004
  10. ncbi request reprint Mechanisms of late cardiovascular toxicity from cancer chemotherapy
    Richard Steingart
    J Clin Oncol 23:9051-2. 2005

Detail Information

Publications11

  1. doi request reprint Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management
    Richard M Steingart
    Memorial Sloan Kettering Cancer Center, New York, NY Electronic address
    Semin Oncol 40:690-708. 2013
    ..The result is a series of recommendations for surveillance and management of cardiovascular disease in cancer survivors. ..
  2. doi request reprint Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
    Richard M Steingart
    Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am Heart J 163:156-63. 2012
    ....
  3. ncbi request reprint Preoperative exercise echocardiography and perioperative cardiovascular outcomes in elderly patients undergoing cancer surgery
    Abu Shoyeb
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Geriatr Cardiol 15:338-44. 2006
    ..9% vs 12.2%; P=.052). In conclusion, EE is feasible in very elderly patients. There is a high prevalence of cardiac abnormalities in the elderly. An abnormal EE predicts PACE, which, in turn, is associated with increased length of stay...
  4. doi request reprint The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Chau Dang
    Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Howard 713, New York, NY 10021, USA
    J Clin Oncol 26:1216-22. 2008
    ..The primary end point was cardiac safety, and the secondary end points were time to recurrence and overall survival...
  5. pmc Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction
    Patrick G Morris
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 27:6117-23. 2009
    ..Dose-dense (dd) AC followed by paclitaxel (P) is superior to the same regimen given every third week. Herein, we report the early cardiac safety of three sequential studies of ddAC alone or with bevacizumab (B)...
  6. pmc Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea
    Chau Dang
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 28:2982-8. 2010
    ..We conducted a pilot study of dose-dense AC followed by PT plus lapatinib (PTL) followed by trastuzumab plus lapatinib (TL)...
  7. doi request reprint Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients
    Jurgen Rademaker
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1270 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 191:32-7. 2008
    ....
  8. doi request reprint Cardiac disease and heart failure in cancer patients: is our training adequate to provide optimal care?
    Carol L Chen
    Cardiology Division, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Howard 809, New York, NY 10065, USA
    Heart Fail Clin 7:357-62. 2011
    ....
  9. ncbi request reprint Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry
    Marc Klapholz
    Saint Vincent Catholic Medical Centers, New York, New York, USA
    J Am Coll Cardiol 43:1432-8. 2004
    ....
  10. ncbi request reprint Mechanisms of late cardiovascular toxicity from cancer chemotherapy
    Richard Steingart
    J Clin Oncol 23:9051-2. 2005
  11. ncbi request reprint Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock
    Michael H Picard
    Massachusetts General Hospital and Harvard Medical School, Boston, Mass 02114, USA
    Circulation 107:279-84. 2003
    ....